Chemoradiotherapy of stage III small‐cell lung cancer: Can we further optimize multimodal treatment of N3 disease based on current evidence?

Eze Chukwuka; Roengvoraphoj Olarn; Schmidt‐Hegemann Nina‐Sophie; K?smann Lukas; Dantes Maurice; Manapov Farkhad

首页> 外文期刊>The clinical respiratory journal. >Chemoradiotherapy of stage III small‐cell lung cancer: Can we further optimize multimodal treatment of N3 disease based on current evidence?

【24h】

Chemoradiotherapy of stage III small‐cell lung cancer: Can we further optimize multimodal treatment of N3 disease based on current evidence?

机译：III阶段小型细胞肺癌的化学疗法：我们可以根据当前证据进一步优化N3疾病的多模式治疗吗？

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The clinical respiratory journal.》 |2018年第10期|共2页
作者
Eze Chukwuka; Roengvoraphoj Olarn; Schmidt‐Hegemann Nina‐Sophie; K?smann Lukas; Dantes Maurice; Manapov Farkhad;
展开▼
作者单位

Department of Radiation OncologyUniversity Hospital LMU MunichMunich Germany;

Department of Radiation OncologyUniversity Hospital LMU MunichMunich Germany;

Department of Radiation OncologyUniversity Hospital LMU MunichMunich Germany;

Department of Radiation OncologyUniversity Hospital LMU MunichMunich Germany;

Department of Radiation OncologyUniversity Hospital LMU MunichMunich Germany;

Department of Radiation OncologyUniversity Hospital LMU MunichMunich Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Chemoradiotherapy of stage III small‐cell lung cancer: Can we further optimize multimodal treatment of N3 disease based on current evidence? [J] . Eze Chukwuka, Roengvoraphoj Olarn, Schmidt‐Hegemann Nina‐Sophie, The clinical respiratory journal. . 2018,第10期

机译：III阶段小型细胞肺癌的化学疗法：我们可以根据当前证据进一步优化N3疾病的多模式治疗吗？
2. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. [J] . Grunenwald DH, Andre F, Le-Pechoux C, The Journal of Thoracic and Cardiovascular Surgery . 2001,第4期

机译：IIIB期（T4和/或N3）非小细胞肺癌放化疗后手术的益处。
3. Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer [J] . Dominique H. Grunenwald, Fabrice Andr??, C??cile Le P??choux, The journal of thoracic and cardiovascular surgery . 2001,第4期

机译：IIIB期（T4和/或N3）非小细胞肺癌放化疗后手术的益处
4. Early Assessment of the Added Value of FDG-PET/CT and MRI-DWI in Monitoring Treatment Response of Stage III Non-Small Cell Lung Cancer [C] . K.R. Siegersma, J.M. Hummel, H. Broekhuizen Mediterranean Conference on Medical and Biological Engineering and Computin . 2016

机译：早期评估FDG-PET / CT和MRI-DWI的增加值监测III期非小细胞肺癌的治疗响应
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Surgery after chemoradiotherapy in patients with stage III (N2 or N3 excluding T4) non-small-cell lung cancer: a systematic review [O] . A. Swaminath, E.T. Vella, K. Ramchandar, 2019

机译：III期（N2或N3不包括T4）非小细胞肺癌患者放化疗后的手术：系统评价
7. Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy [O] . Haruki Kobayashi, Tateaki Naito, Katsuhiro Omae, 2018

机译：间质肺病分类对患有疗效阶段非小细胞肺癌和间质肺病患者急性肺病急性加剧及预后的影响

Chemoradiotherapy of stage III small‐cell lung cancer: Can we further optimize multimodal treatment of N3 disease based on current evidence?

著录项

相似文献

相关主题

期刊订阅